Table of Contents Chapter 1 Overview of Liver Fibrosis Drug 1.1 Definition of Liver Fibrosis Drug in This Report 1.2 Commercial Types of Liver Fibrosis Drug 1.2.1 Interferon 1.2.2 Maloti Lipid 1.2.3 Nucleoside 1.2.4 Other 1.3 Downstream Application of Liver Fibrosis Drug 1.3.1 Research Center 1.3.2 Hospital 1.3.3 Clinic 1.4 Development History of Liver Fibrosis Drug 1.5 Market Status and Trend of Liver Fibrosis Drug 2013-2023 1.5.1 Global Liver Fibrosis Drug Market Status and Trend 2013-2023 1.5.2 Regional Liver Fibrosis Drug Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Liver Fibrosis Drug 2013-2017 2.2 Sales Market of Liver Fibrosis Drug by Regions 2.2.1 Sales Volume of Liver Fibrosis Drug by Regions 2.2.2 Sales Value of Liver Fibrosis Drug by Regions 2.3 Production Market of Liver Fibrosis Drug by Regions 2.4 Global Market Forecast of Liver Fibrosis Drug 2018-2023 2.4.1 Global Market Forecast of Liver Fibrosis Drug 2018-2023 2.4.2 Market Forecast of Liver Fibrosis Drug by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Liver Fibrosis Drug by Types 3.2 Sales Value of Liver Fibrosis Drug by Types 3.3 Market Forecast of Liver Fibrosis Drug by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Liver Fibrosis Drug by Downstream Industry 4.2 Global Market Forecast of Liver Fibrosis Drug by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Liver Fibrosis Drug Market Status by Countries 5.1.1 North America Liver Fibrosis Drug Sales by Countries (2013-2017) 5.1.2 North America Liver Fibrosis Drug Revenue by Countries (2013-2017) 5.1.3 United States Liver Fibrosis Drug Market Status (2013-2017) 5.1.4 Canada Liver Fibrosis Drug Market Status (2013-2017) 5.1.5 Mexico Liver Fibrosis Drug Market Status (2013-2017) 5.2 North America Liver Fibrosis Drug Market Status by Manufacturers 5.3 North America Liver Fibrosis Drug Market Status by Type (2013-2017) 5.3.1 North America Liver Fibrosis Drug Sales by Type (2013-2017) 5.3.2 North America Liver Fibrosis Drug Revenue by Type (2013-2017) 5.4 North America Liver Fibrosis Drug Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Liver Fibrosis Drug Market Status by Countries 6.1.1 Europe Liver Fibrosis Drug Sales by Countries (2013-2017) 6.1.2 Europe Liver Fibrosis Drug Revenue by Countries (2013-2017) 6.1.3 Germany Liver Fibrosis Drug Market Status (2013-2017) 6.1.4 UK Liver Fibrosis Drug Market Status (2013-2017) 6.1.5 France Liver Fibrosis Drug Market Status (2013-2017) 6.1.6 Italy Liver Fibrosis Drug Market Status (2013-2017) 6.1.7 Russia Liver Fibrosis Drug Market Status (2013-2017) 6.1.8 Spain Liver Fibrosis Drug Market Status (2013-2017) 6.1.9 Benelux Liver Fibrosis Drug Market Status (2013-2017) 6.2 Europe Liver Fibrosis Drug Market Status by Manufacturers 6.3 Europe Liver Fibrosis Drug Market Status by Type (2013-2017) 6.3.1 Europe Liver Fibrosis Drug Sales by Type (2013-2017) 6.3.2 Europe Liver Fibrosis Drug Revenue by Type (2013-2017) 6.4 Europe Liver Fibrosis Drug Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Liver Fibrosis Drug Market Status by Countries 7.1.1 Asia Pacific Liver Fibrosis Drug Sales by Countries (2013-2017) 7.1.2 Asia Pacific Liver Fibrosis Drug Revenue by Countries (2013-2017) 7.1.3 China Liver Fibrosis Drug Market Status (2013-2017) 7.1.4 Japan Liver Fibrosis Drug Market Status (2013-2017) 7.1.5 India Liver Fibrosis Drug Market Status (2013-2017) 7.1.6 Southeast Asia Liver Fibrosis Drug Market Status (2013-2017) 7.1.7 Australia Liver Fibrosis Drug Market Status (2013-2017) 7.2 Asia Pacific Liver Fibrosis Drug Market Status by Manufacturers 7.3 Asia Pacific Liver Fibrosis Drug Market Status by Type (2013-2017) 7.3.1 Asia Pacific Liver Fibrosis Drug Sales by Type (2013-2017) 7.3.2 Asia Pacific Liver Fibrosis Drug Revenue by Type (2013-2017) 7.4 Asia Pacific Liver Fibrosis Drug Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Liver Fibrosis Drug Market Status by Countries 8.1.1 Latin America Liver Fibrosis Drug Sales by Countries (2013-2017) 8.1.2 Latin America Liver Fibrosis Drug Revenue by Countries (2013-2017) 8.1.3 Brazil Liver Fibrosis Drug Market Status (2013-2017) 8.1.4 Argentina Liver Fibrosis Drug Market Status (2013-2017) 8.1.5 Colombia Liver Fibrosis Drug Market Status (2013-2017) 8.2 Latin America Liver Fibrosis Drug Market Status by Manufacturers 8.3 Latin America Liver Fibrosis Drug Market Status by Type (2013-2017) 8.3.1 Latin America Liver Fibrosis Drug Sales by Type (2013-2017) 8.3.2 Latin America Liver Fibrosis Drug Revenue by Type (2013-2017) 8.4 Latin America Liver Fibrosis Drug Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Liver Fibrosis Drug Market Status by Countries 9.1.1 Middle East and Africa Liver Fibrosis Drug Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Liver Fibrosis Drug Revenue by Countries (2013-2017) 9.1.3 Middle East Liver Fibrosis Drug Market Status (2013-2017) 9.1.4 Africa Liver Fibrosis Drug Market Status (2013-2017) 9.2 Middle East and Africa Liver Fibrosis Drug Market Status by Manufacturers 9.3 Middle East and Africa Liver Fibrosis Drug Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Liver Fibrosis Drug Sales by Type (2013-2017) 9.3.2 Middle East and Africa Liver Fibrosis Drug Revenue by Type (2013-2017) 9.4 Middle East and Africa Liver Fibrosis Drug Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Liver Fibrosis Drug 10.1 Global Economy Situation and Trend Overview 10.2 Liver Fibrosis Drug Downstream Industry Situation and Trend Overview Chapter 11 Liver Fibrosis Drug Market Competition Status by Major Manufacturers 11.1 Production Volume of Liver Fibrosis Drug by Major Manufacturers 11.2 Production Value of Liver Fibrosis Drug by Major Manufacturers 11.3 Basic Information of Liver Fibrosis Drug by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Liver Fibrosis Drug Major Manufacturer 11.3.2 Employees and Revenue Level of Liver Fibrosis Drug Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Liver Fibrosis Drug Major Manufacturers Introduction and Market Data 12.1 Bird Rock Bio, Inc. 12.1.1 Company profile 12.1.2 Representative Liver Fibrosis Drug Product 12.1.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Bird Rock Bio, Inc. 12.2 Bristol-Myers Squibb Company 12.2.1 Company profile 12.2.2 Representative Liver Fibrosis Drug Product 12.2.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company 12.3 Celgene Corporation 12.3.1 Company profile 12.3.2 Representative Liver Fibrosis Drug Product 12.3.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Celgene Corporation 12.4 Dicerna Pharmaceuticals, Inc. 12.4.1 Company profile 12.4.2 Representative Liver Fibrosis Drug Product 12.4.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Dicerna Pharmaceuticals, Inc. 12.5 Digna Biotech, S.L. 12.5.1 Company profile 12.5.2 Representative Liver Fibrosis Drug Product 12.5.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Digna Biotech, S.L. 12.6 Genfit SA 12.6.1 Company profile 12.6.2 Representative Liver Fibrosis Drug Product 12.6.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Genfit SA 12.7 Gilead Sciences, Inc. 12.7.1 Company profile 12.7.2 Representative Liver Fibrosis Drug Product 12.7.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Gilead Sciences, Inc. 12.8 GNI Group Ltd. 12.8.1 Company profile 12.8.2 Representative Liver Fibrosis Drug Product 12.8.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of GNI Group Ltd. 12.9 HEC Pharm Co., Ltd. 12.9.1 Company profile 12.9.2 Representative Liver Fibrosis Drug Product 12.9.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of HEC Pharm Co., Ltd. 12.10 Dr. Falk Pharma GmbH 12.10.1 Company profile 12.10.2 Representative Liver Fibrosis Drug Product 12.10.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Dr. Falk Pharma GmbH 12.11 LG Life Science LTD. 12.11.1 Company profile 12.11.2 Representative Liver Fibrosis Drug Product 12.11.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of LG Life Science LTD. 12.12 Nitto Denko Corporation 12.12.1 Company profile 12.12.2 Representative Liver Fibrosis Drug Product 12.12.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Nitto Denko Corporation 12.13 Pfizer Inc. 12.13.1 Company profile 12.13.2 Representative Liver Fibrosis Drug Product 12.13.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Pfizer Inc. 12.14 Pharmaxis Limited 12.14.1 Company profile 12.14.2 Representative Liver Fibrosis Drug Product 12.14.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Pharmaxis Limited 12.15 Promedior, Inc. 12.15.1 Company profile 12.15.2 Representative Liver Fibrosis Drug Product 12.15.3 Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Promedior, Inc. 12.16 Dynavax Technologies Corporation 12.17 Evotec AG 12.18 FibroGen, Inc. Chapter 13 Upstream and Downstream Market Analysis of Liver Fibrosis Drug 13.1 Industry Chain of Liver Fibrosis Drug 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Liver Fibrosis Drug 14.1 Cost Structure Analysis of Liver Fibrosis Drug 14.2 Raw Materials Cost Analysis of Liver Fibrosis Drug 14.3 Labor Cost Analysis of Liver Fibrosis Drug 14.4 Manufacturing Expenses Analysis of Liver Fibrosis Drug Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Interferon Table Advantage and Disadvantage of Maloti Lipid Table Advantage and Disadvantage of Nucleoside Table Advantage and Disadvantage of Other Table Sales Volume of Liver Fibrosis Drug by Regions 2013-2017 Table Sales Value of Liver Fibrosis Drug by Regions 2013-2017 Table Production Volume of Liver Fibrosis Drug by Regions 2013-2017 Table Global Sales Volume of Liver Fibrosis Drug by Regions 2018-2023 Table Global Sales Value of Liver Fibrosis Drug by Regions 2018-2023 Table Global Production Volume of Liver Fibrosis Drug by Regions 2018-2023 Table Sales Volume of Liver Fibrosis Drug by Types 2013-2017 Table Sales Value of Liver Fibrosis Drug by Types 2013-2017 Table Sales Volume Forecast of Liver Fibrosis Drug by Types 2018-2023 Table Sales Value Forecast of Liver Fibrosis Drug by Types 2018-2023 Table Sales Volume of Liver Fibrosis Drug by Downstream Industry 2013-2017 Table Sales Volume Forecast of Liver Fibrosis Drug by Downstream Industry 2018-2023 Table North America Liver Fibrosis Drug Sales by Countries (2013-2017) Table North America Liver Fibrosis Drug Sales Share by Countries (2013-2017) Table North America Liver Fibrosis Drug Revenue by Countries (2013-2017) Table North America Liver Fibrosis Drug Revenue Market Share by Countries (2013-2017) Table North America Liver Fibrosis Drug Sales by Type (2013-2017) Table North America Liver Fibrosis Drug Sales Share by Type (2013-2017) Table North America Liver Fibrosis Drug Revenue by Type (2013-2017) Table North America Liver Fibrosis Drug Revenue Share by Type (2013-2017) Table North America Liver Fibrosis Drug Sales by Downstream Industry (2013-2017) Table North America Liver Fibrosis Drug Sales Share by Downstream Industry (2013-2017) Table Europe Liver Fibrosis Drug Sales by Countries (2013-2017) Table Europe Liver Fibrosis Drug Sales Share by Countries (2013-2017) Table Europe Liver Fibrosis Drug Revenue by Countries (2013-2017) Table Europe Liver Fibrosis Drug Revenue Market Share by Countries (2013-2017) Table Europe Liver Fibrosis Drug Sales by Type (2013-2017) Table Europe Liver Fibrosis Drug Sales Share by Type (2013-2017) Table Europe Liver Fibrosis Drug Revenue by Type (2013-2017) Table Europe Liver Fibrosis Drug Revenue Share by Type (2013-2017) Table Europe Liver Fibrosis Drug Sales by Downstream Industry (2013-2017) Table Europe Liver Fibrosis Drug Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Liver Fibrosis Drug Sales by Countries (2013-2017) Table Asia Pacific Liver Fibrosis Drug Sales Share by Countries (2013-2017) Table Asia Pacific Liver Fibrosis Drug Revenue by Countries (2013-2017) Table Asia Pacific Liver Fibrosis Drug Revenue Market Share by Countries (2013-2017) Table Asia Pacific Liver Fibrosis Drug Sales by Type (2013-2017) Table Asia Pacific Liver Fibrosis Drug Sales Share by Type (2013-2017) Table Asia Pacific Liver Fibrosis Drug Revenue by Type (2013-2017) Table Asia Pacific Liver Fibrosis Drug Revenue Share by Type (2013-2017) Table Asia Pacific Liver Fibrosis Drug Sales by Downstream Industry (2013-2017) Table Asia Pacific Liver Fibrosis Drug Sales Share by Downstream Industry (2013-2017) Table Latin America Liver Fibrosis Drug Sales by Countries (2013-2017) Table Latin America Liver Fibrosis Drug Sales Share by Countries (2013-2017) Table Latin America Liver Fibrosis Drug Revenue by Countries (2013-2017) Table Latin America Liver Fibrosis Drug Revenue Market Share by Countries (2013-2017) Table Latin America Liver Fibrosis Drug Sales by Type (2013-2017) Table Latin America Liver Fibrosis Drug Sales Share by Type (2013-2017) Table Latin America Liver Fibrosis Drug Revenue by Type (2013-2017) Table Latin America Liver Fibrosis Drug Revenue Share by Type (2013-2017) Table Latin America Liver Fibrosis Drug Sales by Downstream Industry (2013-2017) Table Latin America Liver Fibrosis Drug Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Sales by Regions (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Sales Share by Regions (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Revenue by Regions (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Sales by Type (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Sales Share by Type (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Revenue by Type (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Revenue Share by Type (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Sales by Downstream Industry (2013-2017) Table Middle East and Africa Liver Fibrosis Drug Sales Share by Downstream Industry (2013-2017) Table Production Volume of Liver Fibrosis Drug by Major Manufacturers 2013-2017 Table Production Value of Liver Fibrosis Drug by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Liver Fibrosis Drug Major Manufacturer Table Employees and Revenue Level of Liver Fibrosis Drug Major Manufacturer Table Representative Liver Fibrosis Drug Product One of Bird Rock Bio, Inc. Table Representative Liver Fibrosis Drug Product Two of Bird Rock Bio, Inc. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Bird Rock Bio, Inc. 2013-2017 Table Representative Liver Fibrosis Drug Product One of Bristol-Myers Squibb Company Table Representative Liver Fibrosis Drug Product Two of Bristol-Myers Squibb Company Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company 2013-2017 Table Representative Liver Fibrosis Drug Product One of Celgene Corporation Table Representative Liver Fibrosis Drug Product Two of Celgene Corporation Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Celgene Corporation 2013-2017 Table Representative Liver Fibrosis Drug Product One of Dicerna Pharmaceuticals, Inc. Table Representative Liver Fibrosis Drug Product Two of Dicerna Pharmaceuticals, Inc. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Dicerna Pharmaceuticals, Inc. 2013-2017 Table Representative Liver Fibrosis Drug Product One of Digna Biotech, S.L. Table Representative Liver Fibrosis Drug Product Two of Digna Biotech, S.L. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Digna Biotech, S.L. 2013-2017 Table Representative Liver Fibrosis Drug Product One of Genfit SA Table Representative Liver Fibrosis Drug Product Two of Genfit SA Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Genfit SA 2013-2017 Table Representative Liver Fibrosis Drug Product One of Gilead Sciences, Inc. Table Representative Liver Fibrosis Drug Product Two of Gilead Sciences, Inc. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Gilead Sciences, Inc. 2013-2017 Table Representative Liver Fibrosis Drug Product One of GNI Group Ltd. Table Representative Liver Fibrosis Drug Product Two of GNI Group Ltd. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of GNI Group Ltd. 2013-2017 Table Representative Liver Fibrosis Drug Product One of HEC Pharm Co., Ltd. Table Representative Liver Fibrosis Drug Product Two of HEC Pharm Co., Ltd. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of HEC Pharm Co., Ltd. 2013-2017 Table Representative Liver Fibrosis Drug Product One of Dr. Falk Pharma GmbH Table Representative Liver Fibrosis Drug Product Two of Dr. Falk Pharma GmbH Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Dr. Falk Pharma GmbH 2013-2017 Table Representative Liver Fibrosis Drug Product One of LG Life Science LTD. Table Representative Liver Fibrosis Drug Product Two of LG Life Science LTD. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of LG Life Science LTD. 2013-2017 Table Representative Liver Fibrosis Drug Product One of Nitto Denko Corporation Table Representative Liver Fibrosis Drug Product Two of Nitto Denko Corporation Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Nitto Denko Corporation 2013-2017 Table Representative Liver Fibrosis Drug Product One of Pfizer Inc. Table Representative Liver Fibrosis Drug Product Two of Pfizer Inc. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Pfizer Inc. 2013-2017 Table Representative Liver Fibrosis Drug Product One of Pharmaxis Limited Table Representative Liver Fibrosis Drug Product Two of Pharmaxis Limited Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Pharmaxis Limited 2013-2017 Table Representative Liver Fibrosis Drug Product One of Promedior, Inc. Table Representative Liver Fibrosis Drug Product Two of Promedior, Inc. Table Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin of Promedior, Inc. 2013-2017